News | Cardiovascular Education | July 23, 2024

International Atherosclerosis Society Issues New White Paper Underscoring Inflammation's Role, Offering Key Recommendations

The International Atherosclerosis Society (IAS) has released a clinical proceedings white paper outlining the role of inflammation in atherosclerosis and the importance of early intervention. The new paper is part of IAS’ Clinical Proceedings, a white paper series, which offers informational resources intended to raise awareness and address unmet needs in atherosclerosis.

The International Atherosclerosis Society (IAS) has released a clinical proceedings white paper outlining the role of inflammation in atherosclerosis and the importance of early intervention. The paper is part of IAS’ Clinical Proceedings, a white paper series, which offers informational resources intended to raise awareness and address unmet needs in atherosclerosis. Image courtesy: IAS


July 23, 2024 — The International Atherosclerosis Society (IAS) has released a clinical proceedings white paper outlining the role of inflammation in atherosclerosis and the importance of early intervention. The new paper, “Assessment & Treatment of Inflammation in Atherosclerosis,” is part of IAS’ Clinical Proceedings, a white paper series, offering informational resources intended to raise awareness and address unmet needs in atherosclerosis.

In issuing this latest white paper, IAS recognized the four international expert panel members who contributed to its development:

- Peter Libby, MD (US), Mallinckrodt Professor of Medicine & Cardiovascular Specialist at Harvard Medical School and Brigham and Womens Hospital, who is IAS President and served as White Paper Panel Chair;

- Jessica M. Peña, MD, MPH, FACC, FNLA (US), Associate Professor of Clinical Medicine, Medicine and Associate Professor of Medicine in Clinical Radiology, Weill Cornell Medical College;

- Wolfgang Koenig, MD, FRCP, FESC, FACC, FAHA (Germany), German Heart Center in Munich; and 

- Hiroaki Shimokawa, MD, PhD (Japan), Professor and Chairman, Division of Cardiovascular Medicine, Tohoku University Graduate School of Medicine

The four main sections addressed in the clinical proceedings white paper include:

  • The role of inflammation in atherosclerosis is explained, noting that local inflammation in the artery wall participates directly in the development of the condition. Systemic, chronic inflammation can also promote the advancement of atherosclerosis and increase the risk of developing cardiovascular diseases.
  • Using biomarkers to identify inflammatory risk in individual patients is now possible. Assessing levels of high-sensitivity CRP specifically can be used to help determine therapeutic strategies that may reduce the risk of major cardiovascular events.
  • Interventions that may mitigate inflammatory risk include lifestyle modifications as well as pharmaceutical interventions. Policy changes could also mitigate the inflammatory risk of atherosclerosis.
  • The burdens of disease are substantial. Atherosclerosis results in significant loss of life and greatly impacts household finances and economies worldwide.

"Atherosclerosis is a primary cause of cardiovascular disease, the leading cause of death worldwide. This paper underscores the persistent need for a more complete understanding of the role of inflammation in atherosclerosis progression among physicians globally, how to identify such inflammation, and how to mitigate the inflammation-associated risk of adverse cardiovascular events,” said Libby. He further stated, “These steps are of the utmost importance for the development of effective treatment strategies that can reduce the morbidity and mortality caused by atherosclerotic cardiovascular disease."

Established in 1979, the International Atherosclerosis Society is a global network of the world’s leading atherosclerotic cardiovascular disease experts who collaborate to develop mission centered programming that spans geographical and generational boundaries.

More information: www.athero.org


Related Content

News | Cardiovascular Education

June 30, 2025 — A new ESC Clinical Consensus Statement published in the European Heart Journal discusses the key role of ...

Home July 09, 2025
Home
News | Cardiovascular Education

May 15, 2025 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of ...

Home May 16, 2025
Home
News | Cardiovascular Education

The American Heart Association recently announced that Dr. Christine E. Seidman, an internationally renowned physician ...

Home May 02, 2025
Home
News | Cardiovascular Education

April 10, 2025 — The American College of Cardiology’s (ACC’s) five-year Strategic Plan includes a major initiative ...

Home April 10, 2025
Home
News | Cardiovascular Education

Feb. 10, 2025 — A generous gift of $5 million from Lorraine and Bill Dodero will establish the Lorraine and Bill Dodero ...

Home February 14, 2025
Home
News | Cardiovascular Education

Aug. 8, 2024 — Radiation from X-rays is an occupational hazard for many medical specialists, including cardiologists ...

Home August 08, 2024
Home
News | Cardiovascular Education

July 26, 2024 — VentriJect, a Danish medtech start-up seeking to revolutionize the way cardiorespiratory fitness (CRF) ...

Home July 26, 2024
Home
News | Cardiovascular Education

May 31, 2024 — In the United States there are over 8 million active athletes. Given the rapid expansion of sports ...

Home May 31, 2024
Home
News | Cardiovascular Education

April 25, 2024 —Heart-Valve-Surgery.com, a leading patient advocacy group for heart valve disease, with support from ...

Home April 25, 2024
Home
News | Cardiovascular Education

March 21, 2024 — The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of ...

Home March 21, 2024
Home
Subscribe Now